Skip to main content

Cabometyx

Pronunciation: Ka-boe-met-iks
Generic name: cabozantinib
Dosage form: oral tablet (20 mg, 40 mg, 60 mg)
Drug classes: Multikinase inhibitors, VEGF/VEGFR inhibitors

Medically reviewed by Judith Stewart, BPharm. Last updated on Mar 26, 2025.

What is Cabometyx?

Cabometyx is an oral tablet taken once a day that is used to treat:

Cabometyx is a kinase inhibitor that blocks the action of several tyrosine kinases involved in normal cellular function and processes that support cancer formation, growth, spread, and maintenance of the tumor microenvironment.

Cabometyx (cabozantinib) first gained FDA approval on November 29, 2012. There is no generic.

Warnings

Cabometyx may cause a perforation (a hole or tear) or a fistula (an abnormal passageway) within your stomach or intestines. This medicine can also increase your risk of serious bleeding.

Call your doctor if you have: severe stomach pain, choking or gagging when you eat or drink, unusual bleeding, bloody or tarry stools, heavy menstrual bleeding, or if you cough up blood.

Before taking this medicine

To make sure Cabometyx is safe for you, tell your doctor if you have:

You may need to have a negative pregnancy test before starting this treatment.

Cabozantinib may harm an unborn baby. Use effective birth control to prevent pregnancy while you are using Cabometyx and for at least 4 months after your last dose. Tell your doctor if you think you might be pregnant.

Cabozantinib may affect fertility (ability to have children) in both men and women. However, it is important to use birth control to prevent pregnancy because Cabometyx can harm an unborn baby.

You should not breastfeed while using Cabometyx, and for at least 4 months after your last dose.

How should I take Cabometyx?

Take Cabometyx exactly as prescribed by your doctor. Follow all directions on your prescription label and read all medication guides or instruction sheets. Your doctor may occasionally change your dose.

Take Cabometyx on an empty stomach, at least 1 hour before or 2 hours after you eat anything.

When used with Cabometyx, nivolumab is usually given as an infusion into a vein once every 2 to 4 weeks.

Your blood pressure, thyroid, and liver function may need to be checked often.

If you need surgery or dental work, stop taking Cabometyx at least 3 weeks ahead of time. After a surgery or dental procedure, you may need to wait 2 weeks before you start taking Cabometyx again. Follow your doctor's dosing instructions very carefully.

If you have stopped taking Cabometyx for any reason, talk with your doctor before you start taking it again.

Store at room temperature away from moisture and heat.

Dosing information

Usual Adult Dose for Renal Cell Carcinoma:

Usual Adult Dose for Hepatocellular Carcinoma:

Usual Adult Dose and Pediatric Dose for Differentiated Thyroid Cancer and Neuroendocrine Tumors

What happens if I miss a dose?

Take the medicine as soon as you can, but skip the missed dose if your next dose is due in less than 12 hours. Do not use two doses at one time.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while taking Cabometyx?

Grapefruit may interact with Cabometyx and lead to unwanted side effects. Avoid the use of grapefruit products while taking cabozantinib.

Avoid taking an herbal supplement containing St. John's wort.

Cabometyx side effects

Get emergency medical help if you have signs of an allergic reaction to Cabometyx: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Cabometyx may cause a perforation (a hole or tear) or a fistula (an abnormal passageway) within your stomach or intestines. Call your doctor if you have severe stomach pain, or if you feel like you are choking and gagging when you eat or drink.

Call your doctor at once if you have:

Your future doses of cabozantinib may be delayed or permanently discontinued if you have certain side effects.

Common Cabometyx side effects may include:

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect Cabometyx?

Sometimes it is not safe to use certain medications at the same time. Some drugs can affect your blood levels of other drugs you take, which may increase side effects or make the medications less effective.

Other drugs may interact with cabozantinib, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.

Does Cabometyx interact with my other drugs?

Enter medications to view a detailed interaction report using our Drug Interaction Checker.

Popular FAQ

How long do you take Cabometyx for?

Cabometyx (cabozantinib) is taken until disease progression - the cancer starts to get worse - or you can no longer tolerate therapy because of the side effects or adverse reactions.

In clinical trials the median amount of time patients took Cabometyx for before their cancer progressed was:

  • METEOR trial - 7.4 months (95% CI 5.6, 9.1)
  • CABOSUN trial - 8.6 months (95% CI 6.8, 14.0)
  • CELESTIAL trial - 5.2 months (95% CI 4.0, 5.5)
  • CHECKMATE-9ER trial - 16.6 months (95% CI 12.5, 24.9)
  • COSMIC-311 - 11 months (95% CI 7.4, 13.8)
Continue reading
What is the success rate of Cabometyx (cabozantinib)?

How successful Cabometyx (cabozantinib) is can be measured by how:

  • Long patients take the treatment for
  • Long patients survive for without their cancer getting worse (progression-free survival)
  • Many months patients remain alive for while taking the treatment
  • Many patients respond to the drug
Continue reading
Is Cabometyx a chemotherapy drug?

Cabometyx (cabozantinib) is a targeted treatment that targets specific enzymes that are more commonly associated with cancer growth and works differently from traditional chemotherapy agents that kill all cells (both healthy and cancerous) that are in the process of dividing. However, Cabometyx is used to treat cancer, and some people may refer to it as chemotherapy, although a targeted treatment is the more correct term. Continue reading

Does Cabometyx (cabozantinib) cure cancer?

Cabometyx (cabozantinib) does not cure advanced renal cell carcinoma (kidney cancer), hepatocellular carcinoma (liver cancer), advanced or metastatic differentiated thyroid cancer, or pancreatic and extra-pancreatic neuroendocrine tumors. Instead it helps to slow the progression of cancer, potentially enabling patients to live longer. Continue reading

How does Cabometyx work?

Cabometyx (cabozantinib) is a tyrosine kinase inhibitor, which works by helping to stop the out-of-control growth that cancer cells display.

Carbometyx works by blocking the signals between cells that promote the growth of new blood vessels and encourage cells to divide and grow. In doing so, it decreases the ability of tumors to spread (metastasize) to other parts of the body and invade surrounding areas. Continue reading

What is the difference between Cabometyx and Cometriq?

Cabometyx and Cometriq are two brand name drugs that both contain the same active ingredient cabozantinib, but they are not interchangeable.

Cabometyx comes in the form of a tablet (20, 40 and 60 mg) and is used to treat advanced renal cell carcinoma (RCC), advanced RCC as a first-line treatment in combination with nivolumab, hepatocellular carcinoma (HCC) in patients who have previously been treated with sorafenib, certain types of differentiated thyroid cancer, and pancreatic or extra-pancreatic neuroendocrine tumors (pNET and epNET).

Cometriq comes in the form of a capsule (20 and 80 mg) and is used to treat progressive metastatic medullary thyroid cancer. Continue reading

View more FAQ

Further information

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use Cabometyx only for the indication prescribed.

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.